申请人:Sterling Drug Inc.
公开号:US04171371A1
公开(公告)日:1979-10-16
Beta-diketones substituted by an aryl-aliphatic group in which the aliphatic chain is interrupted by a cyclic group, and useful as anti-viral agents, are prepared by interacting the appropriate aryl-aliphatic halide with an alkali metal salt of a beta-diketone.
通过将适当的芳基-脂肪卤代物与
β-二酮的碱
金属盐相互作用,制备了被芳基-脂肪基团取代的
β-二酮,其中脂肪链被环状基团中断,并且这些
β-二酮可用作抗病毒剂。